Viral Clearance Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2024-2032
Description
Viral Clearance Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2024-2032
Growth Factors of Viral Clearance Market
The viral clearance market size was valued at USD 621.1 million in 2020, and the market is now projected to grow from USD 718.4 million in 2021 to USD 2644.2 million by 2028, exhibiting a CAGR of 17.7% during the forecast period of 2021-2028.
The COVID-19 crisis increased the need for viral clearance. The demand for providers and products went up quickly. Pharmaceutical companies had to work harder to make vaccines and medicines. They made a lot of biologics and viral vectors. This led to a greater need for strong viral inactivation steps. This made the products safer and more effective. There were also problems with the supply chains and making the products. This made it hard to get viral clearance reagents, causing delays and not enough supply.
The viral clearance industry segment has grown tremendously in recent years and the overall drivers appear to be several. Apart from increasing sales of biopharmaceuticals such as vaccines, antibodies and gene therapy, which has created a strong demand to ensure the safety of products with proper disposal methods, chronic diseases and illnesses the increasing incidence of infectious disease worldwide has increased the importance of biopharmaceuticals, leading to more research and development in this area. The demand for viral clearance solutions has also been increased. All of these factors are amplifying the viral clearance market growth.
High-tech advances, specifically in chromatography, filtration and viral inactivation, have raised the efficiency, and made the processes more effective in viral clearance, thanks to the introduction of these modern approaches. These technological innovations have helped bio-pharma develop efficient manufacturing processes, produce quality products and comply with stringent regulations in addition to the requirements of developing countries and biopharmaceutical industries is transmitted, especially in developing countries Increase The biotechnology industry is highly dynamic and rapidly growing. Thus, as it grows and improves, the virus removal market is predicted to witness a steady growth in the near future.
Comprehensive Analysis of Viral Clearance Market
The viral clearance industry segment has grown tremendously in recent years and the overall drivers appear to be several. The growing commercialization of biopharmaceuticals including vaccines, monoclonal antibodies and gene therapy maintains the need to ensure product safety through stringent virus elimination techniques. The demand for viral clearance solutions has also been increased.
North America becomes the most important region in the viral clearance market share, supported by a number of factors. The area is an important home for bio-Industries which include lots of pharmaceutical and biotech companies doing an extensive amount of research and development work. Furthermore, strict guideline set up by agencies like FDA and Health Canada for clearing the adverse viral conditions together has an effect on the technology and the processes of advanced viral clearance. In addition, North America has a very well developed healthcare system and a strong investment in biopharmaceutical manufacturing facilities which are also very important factors that enhance its dominance in the viral clearance market. With a significant focus on innovation and quality assurance, the North American region should retain its leadership status as the viral clearance market's most prominent producer.
The top players in the market play a crucial role in shaping the industry's growth trajectory and setting market standards. These players include: Pall Corporation (U.S.), Merck KGaA (Germany), Charles River Laboratories International, Inc. (U.S.), Sartorius AG (Germany), Lonza Group AG (Switzerland), WuXi Biologics (China), Sigma-Aldrich Corporation (U.S.), Clean Cells (France), Avance Biosciences, Inc. (U.S.), Texcell (France).
In January 2022, Texcell revealed the highly tailored method “the Virus Counterflow Centrifugation (VCC) method” by using centrifugal force which is substantially efficient to remove viruses from biopharmaceutical products ensuring consequently safety and purity. VCC method is mostly known for its accurateness and effectiveness that simplify regulatory compliance for biopharmaceutical manufacturers. This innovation implies that Texcell is devoted to the development of viral clearance technologies, which can not only ensure improved product integrity and enhanced industry standards but also lay the foundation for further product innovations.
Segmentation Table
Attribute Details
Study Period 2019-2032
Base Year 2023
Estimated Year 2024
Forecast Period 2024-2032
Historical Period 2019-2022
Growth Rate CAGR of 17.7% from 2024-2032
Unit Value (USD Million)
Segmentation By Method
Viral Removal Method
- Chromatography
- Filtration
- Precipitation
Viral Inactivation Method
- pH Modification
- Solvent Detergent (S/D)
- Pasteurization
- Dry Heat
- Others
Viral Detection Method
- Next Generation Sequencing (NGS)
- Polymerase Chain Reaction (PCR)
- In vivo Assay
- In vitro Assay
- Others
By Application
Blood and Blood Products
Recombinant Proteins
Cellular & Gene Therapy Products
Vaccines
Others
By End-user
Pharmaceutical and Biotech Industry
Academic Research Institutes
CROs
Others
By Geography
North America (By Method, Application, End-user, and Country)
- U.S.
- Canada
Europe (By Method, Application, End-user, and Country/Sub-region)
- Germany
- U.K.
- France
- Italy
- Spain
- Scandinavia
- Rest of Europe
Asia Pacific (By Method, Application, End-user, and Country/Sub-region)
- China
- India
- Japan
- Australia
- Southeast Asia
- Rest of Asia Pacific
Latin America (By Method, Application, End-user, and Country/Sub-region)
- Brazil
- Mexico
- Rest of Latin America
Middle East & Africa (By Method, Application, End-user, and Country/Sub-region)
- South Africa
- GCC
- Rest of the Middle East & Africa
Please Note: It will take 2-3 business days to complete the report upon order confirmation.
Table of Contents
128 Pages
- 1. Introduction
- 1.1. Research Scope
- 1.2. Market Segmentation
- 1.3. Research Methodology
- 1.4. Definitions and Assumptions
- 2. Executive Summary
- 3. Market Dynamics
- 3.1. Market Drivers
- 3.2. Market Restraints
- 3.3. Market Opportunities
- 4. Key Insights
- 4.1. Technological Advancements
- 4.2. Key Industry Trends
- 4.3. Regulatory Scenario
- 4.4. Key Industry Developments (Mergers, Acquisitions, Partnerships, etc.)
- 4.5. Impact of COVID-19 on the Market
- 5. Global Viral Clearance Market Analysis, Insights and Forecast, 2019-2032
- 5.1. Market Analysis, Insights and Forecast – By Method
- 5.1.1. Viral Removal Method
- 5.1.1.1. Chromatography
- 5.1.1.2. Filtration
- 5.1.1.3. Precipitation
- 5.1.2. Viral Inactivation Method
- 5.1.2.1. pH Modification
- 5.1.2.2. Solvent Detergent (S/D)
- 5.1.2.3. Pasteurization
- 5.1.2.4. Dry Heat
- 5.1.2.5. Others
- 5.1.3. Viral Detection Method
- 5.1.3.1. Next Generation Sequencing (NGS)
- 5.1.3.2. Polymerase Chain Reaction (PCR)
- 5.1.3.3. In vivo Assay
- 5.1.3.4. In vitro Assay
- 5.1.3.5. Others
- 5.2. Market Analysis, Insights and Forecast – By Applications
- 5.2.1. Blood and Blood Products
- 5.2.2. Recombinant Proteins
- 5.2.3. Cellular & Gene Therapy Products
- 5.2.4. Vaccines
- 5.2.5. Others
- 5.3. Market Analysis, Insights and Forecast – By End-user
- 5.3.1. Pharmaceutical and Biotech Industry
- 5.3.2. Academic Research Institutes
- 5.3.3. CROs
- 5.3.4. Others
- 5.4. Market Analysis, Insights and Forecast – By Geography
- 5.4.1. North America
- 5.4.2. Europe
- 5.4.3. Asia Pacific
- 5.4.4. Latin America
- 5.4.5. Middle East & Africa
- 6. North America Viral Clearance Market Analysis, Insights and Forecast, 2019-2032
- 6.1. Market Analysis, Insights and Forecast – By Method
- 6.1.1. Viral Removal Method
- 6.1.1.1. Chromatography
- 6.1.1.2. Filtration
- 6.1.1.3. Precipitation
- 6.1.2. Viral Inactivation Method
- 6.1.2.1. pH Modification
- 6.1.2.2. Solvent Detergent (S/D)
- 6.1.2.3. Pasteurization
- 6.1.2.4. Dry Heat
- 6.1.2.5. Others
- 6.1.3. Viral Detection Method
- 6.1.3.1. Next Generation Sequencing (NGS)
- 6.1.3.2. Polymerase Chain Reaction (PCR)
- 6.1.3.3. In vivo Assay
- 6.1.3.4. In vitro Assay
- 6.1.3.5. Others
- 6.2. Market Analysis, Insights and Forecast – By Applications
- 6.2.1. Blood and Blood Products
- 6.2.2. Recombinant Proteins
- 6.2.3. Cellular & Gene Therapy Products
- 6.2.4. Vaccines
- 6.2.5. Others
- 6.3. Market Analysis, Insights and Forecast – By End-user
- 6.3.1. Pharmaceutical and Biotech Industry
- 6.3.2. Academic Research Institutes
- 6.3.3. CROs
- 6.3.4. Others
- 6.4. Market Analysis, Insights and Forecast – By Country
- 6.4.1. U.S.
- 6.4.2. Canada
- 7. Europe Viral Clearance Market Analysis, Insights and Forecast, 2019-2032
- 7.1. Market Analysis, Insights and Forecast – By Method
- 7.1.1. Viral Removal Method
- 7.1.1.1. Chromatography
- 7.1.1.2. Filtration
- 7.1.1.3. Precipitation
- 7.1.2. Viral Inactivation Method
- 7.1.2.1. pH Modification
- 7.1.2.2. Solvent Detergent (S/D)
- 7.1.2.3. Pasteurization
- 7.1.2.4. Dry Heat
- 7.1.2.5. Others
- 7.1.3. Viral Detection Method
- 7.1.3.1. Next Generation Sequencing (NGS)
- 7.1.3.2. Polymerase Chain Reaction (PCR)
- 7.1.3.3. In vivo Assay
- 7.1.3.4. In vitro Assay
- 7.1.3.5. Others
- 7.2. Market Analysis, Insights and Forecast – By Applications
- 7.2.1. Blood and Blood Products
- 7.2.2. Recombinant Proteins
- 7.2.3. Cellular & Gene Therapy Products
- 7.2.4. Vaccines
- 7.2.5. Others
- 7.3. Market Analysis, Insights and Forecast – By End-user
- 7.3.1. Pharmaceutical and Biotech Industry
- 7.3.2. Academic Research Institutes
- 7.3.3. CROs
- 7.3.4. Others
- 7.4. Market Analysis, Insights and Forecast – By Country/Sub-region
- 7.4.1. U.K.
- 7.4.2. Germany
- 7.4.3. France
- 7.4.4. Spain
- 7.4.5. Italy
- 7.4.6. Scandinavia
- 7.4.7. Rest of Europe
- 8. Asia Pacific Viral Clearance Market Analysis, Insights and Forecast, 2019-2032
- 8.1. Market Analysis, Insights and Forecast – By Method
- 8.1.1. Viral Removal Method
- 8.1.1.1. Chromatography
- 8.1.1.2. Filtration
- 8.1.1.3. Precipitation
- 8.1.2. Viral Inactivation Method
- 8.1.2.1. pH Modification
- 8.1.2.2. Solvent Detergent (S/D)
- 8.1.2.3. Pasteurization
- 8.1.2.4. Dry Heat
- 8.1.2.5. Others
- 8.1.3. Viral Detection Method
- 8.1.3.1. Next Generation Sequencing (NGS)
- 8.1.3.2. Polymerase Chain Reaction (PCR)
- 8.1.3.3. In vivo Assay
- 8.1.3.4. In vitro Assay
- 8.1.3.5. Others
- 8.2. Market Analysis, Insights and Forecast – By Applications
- 8.2.1. Blood and Blood Products
- 8.2.2. Recombinant Proteins
- 8.2.3. Cellular & Gene Therapy Products
- 8.2.4. Vaccines
- 8.2.5. Others
- 8.3. Market Analysis, Insights and Forecast – By End-user
- 8.3.1. Pharmaceutical and Biotech Industry
- 8.3.2. Academic Research Institutes
- 8.3.3. CROs
- 8.3.4. Others
- 8.4. Market Analysis, Insights and Forecast – By Country/Sub-region
- 8.4.1. Japan
- 8.4.2. China
- 8.4.3. India
- 8.4.4. Australia
- 8.4.5. Southeast Asia
- 8.4.6. Rest of Asia Pacific
- 9. Latin America Viral Clearance Market Analysis, Insights and Forecast, 2019-2032
- 9.1. Market Analysis, Insights and Forecast – By Method
- 9.1.1. Viral Removal Method
- 9.1.1.1. Chromatography
- 9.1.1.2. Filtration
- 9.1.1.3. Precipitation
- 9.1.2. Viral Inactivation Method
- 9.1.2.1. pH Modification
- 9.1.2.2. Solvent Detergent (S/D)
- 9.1.2.3. Pasteurization
- 9.1.2.4. Dry Heat
- 9.1.2.5. Others
- 9.1.3. Viral Detection Method
- 9.1.3.1. Next Generation Sequencing (NGS)
- 9.1.3.2. Polymerase Chain Reaction (PCR)
- 9.1.3.3. In vivo Assay
- 9.1.3.4. In vitro Assay
- 9.1.3.5. Others
- 9.2. Market Analysis, Insights and Forecast – By Applications
- 9.2.1. Blood and Blood Products
- 9.2.2. Recombinant Proteins
- 9.2.3. Cellular & Gene Therapy Products
- 9.2.4. Vaccines
- 9.2.5. Others
- 9.3. Market Analysis, Insights and Forecast – By End-user
- 9.3.1. Pharmaceutical and Biotech Industry
- 9.3.2. Academic Research Institutes
- 9.3.3. CROs
- 9.3.4. Others
- 9.4. Market Analysis, Insights and Forecast – By Country/Sub-region
- 9.4.1. Brazil
- 9.4.2. Mexico
- 9.4.3. Rest of Latin America
- 10. Middle East & Africa Viral Clearance Market Analysis, Insights and Forecast, 2019-2032
- 10.1. Market Analysis, Insights and Forecast – By Method
- 10.1.1. Viral Removal Method
- 10.1.1.1. Chromatography
- 10.1.1.2. Filtration
- 10.1.1.3. Precipitation
- 10.1.2. Viral Inactivation Method
- 10.1.2.1. pH Modification
- 10.1.2.2. Solvent Detergent (S/D)
- 10.1.2.3. Pasteurization
- 10.1.2.4. Dry Heat
- 10.1.2.5. Others
- 10.1.3. Viral Detection Method
- 10.1.3.1. Next Generation Sequencing (NGS)
- 10.1.3.2. Polymerase Chain Reaction (PCR)
- 10.1.3.3. In vivo Assay
- 10.1.3.4. In vitro Assay
- 10.1.3.5. Others
- 10.2. Market Analysis, Insights and Forecast – By Applications
- 10.2.1. Blood and Blood Products
- 10.2.2. Recombinant Proteins
- 10.2.3. Cellular & Gene Therapy Products
- 10.2.4. Vaccines
- 10.2.5. Others
- 10.3. Market Analysis, Insights and Forecast – By End-user
- 10.3.1. Pharmaceutical and Biotech Industry
- 10.3.2. Academic Research Institutes
- 10.3.3. CROs
- 10.3.4. Others
- 10.4. Market Analysis, Insights and Forecast – By Country/Sub-region
- 10.4.1. GCC
- 10.4.2. South Africa
- 10.4.3. Rest of Middle East & Africa
- 11. Competitive Analysis
- 11.1. Global Market Share Analysis (2023)
- 11.2. Company Profiles
- 11.2.1. Merck KGaA
- 11.2.1.1. Overview
- 11.2.1.2. Products & Services
- 11.2.1.3. SWOT Analysis
- 11.2.1.4. Recent Developments
- 11.2.1.5. Strategies
- 11.2.1.6. Financials (Based on Availability)
- 11.2.2. Wuxi Biologics
- 11.2.2.1. Overview
- 11.2.2.2. Products & Services
- 11.2.2.3. SWOT Analysis
- 11.2.2.4. Recent Developments
- 11.2.2.5. Strategies
- 11.2.2.6. Financials (Based on Availability)
- 11.2.3. Charles River Laboratories
- 11.2.3.1. Overview
- 11.2.3.2. Products & Services
- 11.2.3.3. SWOT Analysis
- 11.2.3.4. Recent Developments
- 11.2.3.5. Strategies
- 11.2.3.6. Financials (Based on Availability)
- 11.2.4. Texcell
- 11.2.4.1. Overview
- 11.2.4.2. Products & Services
- 11.2.4.3. SWOT Analysis
- 11.2.4.4. Recent Developments
- 11.2.4.5. Strategies
- 11.2.4.6. Financials (Based on Availability)
- 11.2.5. Vironova
- 11.2.5.1. Overview
- 11.2.5.2. Products & Services
- 11.2.5.3. SWOT Analysis
- 11.2.5.4. Recent Developments
- 11.2.5.5. Strategies
- 11.2.5.6. Financials (Based on Availability)
- 11.2.6. Kedrion
- 11.2.6.1. Overview
- 11.2.6.2. Products & Services
- 11.2.6.3. SWOT Analysis
- 11.2.6.4. Recent Developments
- 11.2.6.5. Strategies
- 11.2.6.6. Financials (Based on Availability)
- 11.2.7. Clean Cells
- 11.2.7.1. Overview
- 11.2.7.2. Products & Services
- 11.2.7.3. SWOT Analysis
- 11.2.7.4. Recent Developments
- 11.2.7.5. Strategies
- 11.2.7.6. Financials (Based on Availability)
- 11.2.8. ViruSure GmbH
- 11.2.8.1. Overview
- 11.2.8.2. Products & Services
- 11.2.8.3. SWOT Analysis
- 11.2.8.4. Recent Developments
- 11.2.8.5. Strategies
- 11.2.8.6. Financials (Based on Availability)
- 11.2.9. Sartorius AG
- 11.2.9.1. Overview
- 11.2.9.2. Products & Services
- 11.2.9.3. SWOT Analysis
- 11.2.9.4. Recent Developments
- 11.2.9.5. Strategies
- 11.2.9.6. Financials (Based on Availability)
- 11.2.10. Syngene International Limited
- 11.2.10.1. Overview
- 11.2.10.2. Products & Services
- 11.2.10.3. SWOT Analysis
- 11.2.10.4. Recent Developments
- 11.2.10.5. Strategies
- 11.2.10.6. Financials (Based on Availability)
- 11.2.11. Microbiologics
- 11.2.11.1. Overview
- 11.2.11.2. Products & Services
- 11.2.11.3. SWOT Analysis
- 11.2.11.4. Recent Developments
- 11.2.11.5. Strategies
- 11.2.11.6. Financials (Based on Availability)
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
